- Home
- NBY vs ISPC Comparison
NBY vs ISPC Comparison
Compare NBY & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- ISPC
- Stock Information
- Founded
- NBY 2000
- ISPC 2009
- Country
- NBY United States
- ISPC United States
- Employees
- NBY N/A
- ISPC N/A
- Industry
- NBY
- ISPC Precision Instruments
- Sector
- NBY
- ISPC Health Care
- Exchange
- NBY Nasdaq
- ISPC Nasdaq
- Market Cap
- NBY 3.5M
- ISPC 3.1M
- IPO Year
- NBY 2007
- ISPC 2021
- Fundamental
- Price
- NBY $0.62
- ISPC $0.96
- Analyst Decision
- NBY Strong Buy
- ISPC
- Analyst Count
- NBY 1
- ISPC 0
- Target Price
- NBY $0.85
- ISPC N/A
- AVG Volume (30 Days)
- NBY 32.4K
- ISPC 54.5K
- Earning Date
- NBY 08-12-2025
- ISPC 08-05-2025
- Dividend Yield
- NBY N/A
- ISPC N/A
- EPS Growth
- NBY N/A
- ISPC N/A
- EPS
- NBY 0.57
- ISPC N/A
- Revenue
- NBY $9,781,000.00
- ISPC $8,058,631.00
- Revenue This Year
- NBY $23.91
- ISPC $35.93
- Revenue Next Year
- NBY $32.05
- ISPC N/A
- P/E Ratio
- NBY $1.34
- ISPC N/A
- Revenue Growth
- NBY 20.52
- ISPC N/A
- 52 Week Low
- NBY $0.36
- ISPC $0.86
- 52 Week High
- NBY $2.45
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- NBY 56.70
- ISPC 42.09
- Support Level
- NBY $0.58
- ISPC $0.90
- Resistance Level
- NBY $0.64
- ISPC $0.97
- Average True Range (ATR)
- NBY 0.03
- ISPC 0.06
- MACD
- NBY 0.00
- ISPC -0.01
- Stochastic Oscillator
- NBY 62.38
- ISPC 29.07
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.